• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEV:GR

45.835 EUR 1.105 2.47%

As of 14:53:20 ET on 12/18/2014.

Snapshot for Teva Pharmaceutical Industries Ltd (TEV)

Open: 44.402 Day's Range: 44.402 - 45.865 Volume: 4,087
Previous Close: 44.730 52wk Range: 28.145 - 48.360 1-Yr Rtn: +62.94%

Stock Chart for TEV

No chart data available.
  • TEV:GR 45.865
  • 1D
  • 1M
  • 1Y
44.730
Interactive TEV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 11.0864
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 5.0660
Est. PEG Ratio 5.0347
Market Cap (M EUR) 39,091.45
Shares Outstanding (M) 855.00
30 Day Average Volume 3,455
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.22%
Cash Dividend (USD) 0.2696
Dividend Ex-Date 11/13/2014
5 Year Dividend Growth 20.02%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEV

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOItzhak KrinskyChairman:Teva Japan & South Korea
Allan ObermanPresident & CEO:AmericasJudith VardiPresident & CEO:Emia & Asia Pacific
More Company Profile & Key Executives for TEV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil